PSILOCYBIN THERAPY FOR DEPRESSION AND ANXIETY IN PARKINSON'S DISEASE: AN OPEN-LABEL PILOT STUDY

Authors
Category Primary study
Conference63rd Aannual Meeting of the merican College of Neuropsychopharmacology, ACNP 2024
Year 2024
This article has no abstract
Epistemonikos ID: c97b892ea807f51cf60e4527b8504eb2dc34eba2
First added on: Feb 21, 2026